SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-024183
Filing Date
2017-04-18
Accepted
2017-04-18 16:39:11
Documents
2
Period of Report
2017-04-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-11508_18k.htm 8-K 22207
2 EX-99.1 a17-11508_1ex99d1.htm EX-99.1 17242
  Complete submission text file 0001104659-17-024183.txt   40494
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37558 | Film No.: 17767368
SIC: 2834 Pharmaceutical Preparations